Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

NCT07082816 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

489

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Open Angle Glaucoma

Interventions

DRUG: Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution
DRUG: Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution

Sponsor

Alcon Research